| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas (NCT05475925) | Dren Bio | 2022-07-13 |
| Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL (NCT04676789) | Sun Yat-sen University | 2021-09-01 |
| Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial (NCT04602065) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-11-24 |
| A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type (NCT04414163) | ImmuneOncia Therapeutics Inc. | 2020-10-27 |
| Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL (NCT04509466) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-09-15 |
| Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma (NCT04338282) | Beijing Tongren Hospital | 2020-06-01 |
| GPED Regimen for Relapsed/Refractory or Advanced ENKTCL (NCT04405375) | Beijing Tongren Hospital | 2020-03-21 |
| SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma (NCT03363555) | Jiangsu HengRui Medicine Co., Ltd. | 2018-05-29 |
| Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451) | BeiGene | 2018-04-13 |
| Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients (NCT03079544) | Rong Tao | 2017-03-08 |
| MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma (NCT02631239) | Ruijin Hospital | 2016-03-16 |
| CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma (NCT02742727) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-03-01 |
| MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma (NCT02764281) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2015-04-01 |
| Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy (NCT02229682) | Sun Yat-sen University | 2014-10-01 |
| GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma (NCT01991158) | Sun Yat-sen University | 2013-11-01 |
| Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma (NCT01921790) | Sun Yat-sen University | 2013-08-01 |
| International Extranodal NK/T-cell Lymphoma Project (NCT02386813) | Samsung Medical Center | 2013-01-01 |
| Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma (NCT01667289) | Fudan University | 2012-06-01 |
| Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma (NCT01667302) | Fudan University | 2012-06-01 |
| Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma (NCT00901147) | Singapore General Hospital | 2009-11-01 |